279 related articles for article (PubMed ID: 15910568)
1. Surgical treatment of patients with refractory migraine headaches and intranasal contact points.
Behin F; Behin B; Bigal ME; Lipton RB
Cephalalgia; 2005 Jun; 25(6):439-43. PubMed ID: 15910568
[TBL] [Abstract][Full Text] [Related]
2. Endonasal surgery for contact point headaches: a 10-year longitudinal study.
Welge-Luessen A; Hauser R; Schmid N; Kappos L; Probst R
Laryngoscope; 2003 Dec; 113(12):2151-6. PubMed ID: 14660919
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
4. [3-year follow-up after endonasal microscopic paranasal sinus surgery in migraine and cluster headache].
Welge-Lüssen A; Hauser R; Probst R
Laryngorhinootologie; 1996 Jul; 75(7):392-6. PubMed ID: 8924166
[TBL] [Abstract][Full Text] [Related]
5. Rhinologic evaluation in patients with primary headache.
Yazici ZM; Cabalar M; Sayin I; Kayhan FT; Gurer E; Yayla V
J Craniofac Surg; 2010 Nov; 21(6):1688-91. PubMed ID: 21119401
[TBL] [Abstract][Full Text] [Related]
6. Treatment of sinus headache as migraine: the diagnostic utility of triptans.
Kari E; DelGaudio JM
Laryngoscope; 2008 Dec; 118(12):2235-9. PubMed ID: 18948830
[TBL] [Abstract][Full Text] [Related]
7. Headache prevention outcome and body mass index.
Bigal ME; Gironda M; Tepper SJ; Feleppa M; Rapoport AM; Sheftell FD; Lipton RB
Cephalalgia; 2006 Apr; 26(4):445-50. PubMed ID: 16556246
[TBL] [Abstract][Full Text] [Related]
8. Occipital nerve stimulation for chronic headache--long-term safety and efficacy.
Schwedt TJ; Dodick DW; Hentz J; Trentman TL; Zimmerman RS
Cephalalgia; 2007 Feb; 27(2):153-7. PubMed ID: 17257236
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive/tertiary care for headache: a 6-month outcome study.
Saper JR; Lake AE; Madden SF; Kreeger C
Headache; 1999 Apr; 39(4):249-63. PubMed ID: 15613222
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
12. Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases.
Tepper SJ; Bigal ME; Sheftell FD; Rapoport AM
Headache; 2004 Sep; 44(8):794-800. PubMed ID: 15330826
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
14. The Sinus, Allergy and Migraine Study (SAMS).
Eross E; Dodick D; Eross M
Headache; 2007 Feb; 47(2):213-24. PubMed ID: 17300361
[TBL] [Abstract][Full Text] [Related]
15. Migraine changes with age: IMPACT on migraine classification.
Kelman L
Headache; 2006; 46(7):1161-71. PubMed ID: 16866720
[TBL] [Abstract][Full Text] [Related]
16. Evolution of migraine after a 10-year follow-up.
Nachit-Ouinekh F; Dartigues JF; Chrysostome V; Henry P; Sourgen C; El Hasnaoui A
Headache; 2005; 45(10):1280-7. PubMed ID: 16324159
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of an intensive multidisciplinary headache treatment program.
Gunreben-Stempfle B; Griessinger N; Lang E; Muehlhans B; Sittl R; Ulrich K
Headache; 2009 Jul; 49(7):990-1000. PubMed ID: 19473281
[TBL] [Abstract][Full Text] [Related]
18. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
19. Disability and quality of life in different primary headaches: results from Italian studies.
Bussone G; Usai S; Grazzi L; Rigamonti A; Solari A; D'Amico D
Neurol Sci; 2004 Oct; 25 Suppl 3():S105-7. PubMed ID: 15549514
[TBL] [Abstract][Full Text] [Related]
20. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
Miner JR; Smith SW; Moore J; Biros M
Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
